To date, a variety of intracellular signaling pathways including acid ceramidase, fibroblast growth factor 18 and Hedgehog signaling pathways have been shown to act as a modulator of YAP1 activity, thereby altering HSC activation and liver fibrosis (40–42). The gene discussed is ASAH1; the disease is Hepatic fibrosis.